Table 1. Baseline Clinical Characteristics According to Changes of LVDFP.
| Variables | Improved LVDFP (n=379) | Unimproved LVDFP (n=221) | p value |
|---|---|---|---|
| Age (yr) | 66.4±11.1 | 66.2±11.8 | 0.84 |
| Female | 155 (40.9) | 101 (45.7) | 0.27 |
| Body mass index (kg/m2) | 25.8±3.8 | 26.1±4.7 | 0.45 |
| Index PCI or CABG | 39 (10.3) | 22 (10.0) | 0.85 |
| Previous PCI | 65 (17.2) | 34 (15.4) | 0.65 |
| Previous CABG | 12 (3.2) | 7 (3.2) | >0.999 |
| Previous MI | 16 (4.2) | 14 (6.3) | 0.25 |
| Paroxysmal AF | 18 (4.7) | 21 (9.5) | 0.026 |
| Heart failure | 29 (7.7) | 27 (12.2) | 0.07 |
| PPM | 5 (1.4) | 1 (0.5) | 0.80 |
| Diabetes mellitus | 131 (34.6) | 85 (38.5) | 0.38 |
| Hypertension | 272 (71.8) | 164 (74.2) | 0.57 |
| Chronic kidney disease | 30 (7.9) | 27 (12.2) | 0.09 |
| Chronic lung disease | 29 (7.7) | 16 (7.7) | 0.47 |
| Cancer | 39 (10.3) | 22 (10.0) | >0.999 |
| Thyroid diseases | 15 (4.0) | 7 (3.2) | 0.92 |
| CVA | 42 (11.1) | 15 (6.8) | 0.11 |
| Alcohol | 80 (21.1) | 50 (22.6) | 0.68 |
| Smoking | 89 (23.5) | 46 (20.8) | 0.56 |
| Renin-angiotensin system blocker | 150 (42.9) | 91 (47.2) | 0.37 |
| Calcium channel blocker | 155 (44.3) | 77 (39.9) | 0.37 |
| Beta blocker | 105 (30.0) | 70 (36.3) | 0.15 |
| Diuretics | 61 (17.4) | 40 (20.7) | 0.36 |
| Follow-up interval of echocardiography (months) | 33.3 (17.6–57.6) | 28.2 (12.6–45.4) | 0.002 |
LVDFP, left ventricular diastolic filling pattern; AF, atrial fibrillation; CABG, coronary artery bypass graft; CVA, cerebrovascular accident; LV, left ventricle; MI, myocardial infarction; PCI, percutaneous coronary intervention; PPM, permanent pacemaker.
Data are presented as mean±standard deviation, n (%), or median (interquartile range).